872PPhase Ib study (COSMIC-021) of cabozantinib in combination with atezolizumab: Results of the dose escalation stage in patients (pts) with treatment-naïve advanced renal cell carcinoma (RCC). - Agarwal, N; Vaishampayan, U; Green, M; Nucci, F di; Chang, P-Y; Scheffold, C; Pal, S (Annals of Oncology, 2018)